Annual Operating Expenses
$29.75 M
+$5.34 M+21.88%
31 December 2023
Summary:
NKGen Biotech Common Stock annual total operating expenses is currently $29.75 million, with the most recent change of +$5.34 million (+21.88%) on 31 December 2023. NKGN annual operating expenses is now at all-time high.NKGN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$7.46 M
-$164.00 K-2.15%
30 June 2024
Summary:
NKGen Biotech Common Stock quarterly total operating expenses is currently $7.46 million, with the most recent change of -$164.00 thousand (-2.15%) on 30 June 2024. Over the past year, it has increased by +$554.00 thousand (+8.03%). NKGN quarterly operating expenses is now -20.94% below its all-time high of $9.43 million, reached on 31 December 2023.NKGN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGN Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.9% | +8.0% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
NKGN Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +33.6% | -20.9% | +24.4% |
| 5 y | 5 years | at high | +33.6% | -20.9% | +24.4% |
| alltime | all time | at high | +33.6% | -20.9% | +24.4% |
NKGen Biotech Common Stock Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $7.46 M(-2.2%) |
| Mar 2024 | - | $7.62 M(-19.2%) |
| Dec 2023 | $29.75 M | $9.43 M(+36.6%) |
| Sept 2023 | - | $6.90 M(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $6.61 M(-2.8%) |
| Mar 2023 | - | $6.80 M(+8.9%) |
| Dec 2022 | $24.41 M(+9.7%) | $6.25 M(+4.2%) |
| Sept 2022 | - | $6.00 M |
| Dec 2021 | $22.26 M | - |
FAQ
- What is NKGen Biotech Common Stock annual total operating expenses?
- What is the all time high annual operating expenses for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock annual operating expenses year-on-year change?
- What is NKGen Biotech Common Stock quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock quarterly operating expenses year-on-year change?
What is NKGen Biotech Common Stock annual total operating expenses?
The current annual operating expenses of NKGN is $29.75 M
What is the all time high annual operating expenses for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high annual total operating expenses is $29.75 M
What is NKGen Biotech Common Stock annual operating expenses year-on-year change?
Over the past year, NKGN annual total operating expenses has changed by +$5.34 M (+21.88%)
What is NKGen Biotech Common Stock quarterly total operating expenses?
The current quarterly operating expenses of NKGN is $7.46 M
What is the all time high quarterly operating expenses for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high quarterly total operating expenses is $9.43 M
What is NKGen Biotech Common Stock quarterly operating expenses year-on-year change?
Over the past year, NKGN quarterly total operating expenses has changed by +$554.00 K (+8.03%)